Kim Young-Sik, Park Yeonjin, Kim Yongbin, Son Hyo-Eun, Rhee Jinhui, Pyun Chang-Won, Park Chanoh, Kim Hocheol
Department of Herbology, College of Korean Medicine, Woosuk University, Jeonju 54986, Republic of Korea.
Department of Herbal Pharmacology, College of Korean Medicine, Graduate School, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.
Antioxidants (Basel). 2024 Jul 23;13(8):891. doi: 10.3390/antiox13080891.
HT074, a multiherbal mixture containing extracts from flowers and roots, is used in Korean medicine for gastric disorders. This study investigated the protective mechanisms of HT074 against acute reflux esophagitis (RE) in rats. Nitric oxide (NO) production and mRNA expression of antioxidant-related genes (, , , , and ) were evaluated in LPS-induced RAW 264.7 cells. Gastroesophageal reflux (GER) was induced in rats, followed by HT074 (100, 300 mg/kg) or ranitidine (50 mg/kg) administration. Esophageal damage and histological changes were assessed. Gastric pH and protein expression levels of Nrf2, HO-1, SOD, CAT, and GPx-1/2 were measured. HT074 pretreatment reduced NO production and increased the expression of HO-1, CAT, and GPx2 in LPS-induced RAW 264.7 cells. In GER-induced rats, HT074 significantly decreased esophageal lesions and increased the expression of HO-1, SOD, GPx-1/2, and Nrf2. HT074 did not affect gastric pH. These findings suggest that HT074 protects against GER-induced esophagitis by inhibiting NO production and enhancing antioxidant activity. Therefore, HT074 could be a promising therapeutic agent for GER disease.
HT074是一种含有花和根提取物的多草药混合物,在韩医学中用于治疗胃部疾病。本研究调查了HT074对大鼠急性反流性食管炎(RE)的保护机制。在脂多糖诱导的RAW 264.7细胞中评估了一氧化氮(NO)的产生以及抗氧化相关基因(、、、和)的mRNA表达。在大鼠中诱导胃食管反流(GER),随后给予HT074(100、300mg/kg)或雷尼替丁(50mg/kg)。评估食管损伤和组织学变化。测量胃pH值以及Nrf2、HO-1、SOD、CAT和GPx-1/2的蛋白表达水平。HT074预处理降低了脂多糖诱导的RAW 264.7细胞中NO的产生,并增加了HO-1、CAT和GPx2的表达。在GER诱导的大鼠中,HT07显著降低了食管病变,并增加了HO-1、SOD、GPx-1/2和Nrf2的表达。HT074不影响胃pH值。这些发现表明,HT074通过抑制NO产生和增强抗氧化活性来预防GER诱导的食管炎。因此,HT074可能是一种有前途的GER疾病治疗药物。